How long does it take to take Canafenib/Encofenib to achieve the desired effect?

The onset time of canafenib/encorafenib usually varies depending on individual patient differences and tumor types. Generally speaking, initial signs of tumor shrinkage or symptom improvement can be observed after two to four weeks of continuous medication, but achieving the desired effect often requires a longer period of treatment maintenance. For patients with advanced melanoma, if used in combination with binimetinib, significant imaging relief can be observed after about 6 to 8 weeks, and some patients can even experience pain relief and improved quality of life in a shorter period of time.

For patients with colorectal cancer or non-small cell lung cancer, due to differences in tumor drug resistance and slow progression of the disease, Encofenib combination treatment usually requires at least an observation period of 8 to 12 weeks, during which doctors will regularly evaluate changes in efficacy through CT, MRI, etc.

During the treatment process, the importance of regular medication should be emphasized. Missing a dose or stopping medication without authorization may affect the efficacy and risk of drug resistance. In addition, efficacy evaluation not only relies on imaging examinations, but also includes comprehensive judgments from multiple dimensions such as tumor marker changes, symptom improvement, and physical fitness scores. Encofenib is a continuous targeted therapy drug that cannot be completely cured with short-term use. If the treatment is well tolerated and effective, long-term maintenance is usually recommended until the disease progresses or unacceptable side effects occur. Most current guidelines recommend that efficacy evaluation be conducted monthly or every two months, and decisions should be made based on the results whether to continue, adjust the dose, or change the treatment plan.

It should be noted that although encofenib has a rapid effect, some patients may develop secondary drug resistance after 3 to 6 months, so subsequent treatment strategies need to be formulated in advance. In general, 2 to 3 months after taking Encofenib is the critical efficacy window period. During this period, clinicians need to closely monitor tumor dynamics and make timely treatment adjustments based on individual responses to achieve the best treatment effect and extend progression-free survival.

Reference materials:https://www.braftovi.com/